Bolton NHS Foundation Trust has trialed Imprivata Identity Governance (IDG) to help improve patient care across the trust.

Imprivata IDG, which was launched in the UK at the end of February, is an extension of the company’s Identity and Access Management (IAM) solution. It allows hospital trusts to control access to sensitive patient records throughout an employee’s lifecycle. User entitlement policies and controls can also be enforced so that compliance obligations including GDPR requirements are met.

Phillipa Winter, CIO at Bolton NHS FT, saw Imprivata IDG at a conference in the USA before it became available in the UK. Over recent weeks the trust has run a trial which has enabled it to automatically grant users access to the many applications and systems associated with their job roles which they need to work with patients.

Imprivata IDG means clinicians can deliver high-quality care with immediate access to the right systems and patient information, with tight security and detailed audit trails.

“The barriers which have traditionally made it difficult and slow for users to gain timely access to systems have been removed enabling care providers to be more productive, confident that they are complying with data regulations,” Winter added.

Imprivata IDG is part of the fully integrated Imprivata platform for Identity and Access Management which includes Imprivata OneSign Single Sign On, Imprivata Confirm ID for Clinical Workflows, and Imprivata OneSign Spine Combined Workflow.

Wes Wright, chief technology offer at Imprivata, added: “Managing access to sensitive patient information is critical for healthcare organisations. Unwieldy security and slow to provision IT systems lead to frustration for frontline staff.

“When Imprivata Identity Governance is combined with Imprivata OneSign single sign on, users have immediate access to all the data they need to do their job with the simple tap of a badge or token.  Streamlined login times save up to an hour per shift, giving back significant time to care, which has proven extremely popular with clinicians and aids user adoption.”